Abbvie Acquires Apogee
Abbvie is acquiring Apogee Therapeutics in a deal valuing Apogee at $10.9 billion
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Abbvie is acquiring Apogee Therapeutics in a deal valuing Apogee at $10.9 billion
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.